Pamela Wedel

Nessuna posizione attualmente

Health Technology

Consumer Services

Precedenti posizioni note di Pamela Wedel

Società	Posizione	Inizio	Fine
SPRUCE BIOSCIENCES, INC.	Direttore operativo	-	-
SPRUCE BIOSCIENCES, INC.	Corporate Officer/Principal	-	11/10/2022
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Direttore Tecnico/Scientifico/R&S	-	-

San Diego State University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Operating Officer	1
Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SPRUCE BIOSCIENCES, INC.	Health Technology

Aziende private	1
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.	Health Technology

Aziende private

Health Technology